Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 5.

Satheesha, S; Manzella, G; Bovay, A; Casanova, E A; Bode, P K; Belle, R; Feuchtgruber, S; Jaaks, P; Dogan, N; Koscielniak, E; Schäfer, B W (2016). Targeting hedgehog signaling reduces self-renewal in embryonal rhabdomyosarcoma. Oncogene, 35(16):2020-2030.

Paulides, M; Stöhr, W; Laws, H J; Graf, N; Lakomek, M; Berthold, F; Schmitt, K; Niggli, F; Jürgens, H; Bielack, S; Koscielniak, E; Klingebiel, T; Langer, T (2011). Antibody levels against tetanus and diphtheria after polychemotherapy for childhood sarcoma: a report from the Late Effects Surveillance System. Vaccine, 29(8):1565-1568.

Walter, D; Satheesha, S; Albrecht, P; Bornhauser, B C; D'Alessandro, V; Oesch, S M; Rehrauer, H; Leuschner, I; Koscielniak, E; Gengler, C; Moch, H; Bernasconi, M; Niggli, F K; Schäfer, B W (2011). CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres. PLoS ONE, 6(5):e19506.

Paulides, M; Stöhr, W; Laws, H J; Graf, N; Lakomek, M; Berthold, F; Schmitt, K; Niggli, F; Jürgens, H; Bielack, S; Koscielniak, E; Klingebiel, T; Langer, T (2010). Immunity against tetanus and diphtheria after childhood sarcoma treatment. Klinische Pädiatrie, 222(3):196.

Dantonello, T M; Int-Veen, C; Winkler, P; Leuschner, I; Schuck, A; Schmidt, B F; Lochbuehler, H; Kirsch, S; Hallmen, E; Veit-Friedrich, I; Bielack, S S; Niggli, F; Kazanowska, B; Ladenstein, R; Wiebe, T; Klingebiel, T; Treuner, J; Koscielniak, E (2008). Initial patient characteristics can predict pattern and risk of relapse in localized rhabdomyosarcoma. Journal of Clinical Oncology, 26(3):406-413.

This list was generated on Sun Jun 16 11:46:29 2019 CEST.